CEFOTETAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefotetan, and what generic alternatives are available?
Cefotetan is a drug marketed by Fresenius Kabi Usa, Hikma, West-ward Pharm Corp, and B Braun. and is included in five NDAs.
The generic ingredient in CEFOTETAN is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for CEFOTETAN
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 6 |
Patent Applications: | 4,929 |
Drug Prices: | Drug price information for CEFOTETAN |
DailyMed Link: | CEFOTETAN at DailyMed |
Recent Clinical Trials for CEFOTETAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Chonbuk National University Hospital | Phase 1 |
Pharmacology for CEFOTETAN
Drug Class | Cephalosporin Antibacterial |